Dare Bioscience, INC. (DARE) SEC Filings — 2024

Filings

• Dare Bioscience Files 8-K Report — 8-K · Dec 16, 2024
• Dare Bioscience Files S-1 for New Securities Offering — S-1 · Nov 15, 2024
• Dare Bioscience Files 8-K on Financials — 8-K · Nov 14, 2024
• Dare Bioscience Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Dare Bioscience, INC. 8-K Filing — 8-K · Oct 25, 2024
• Dare Bioscience Files 8-K with Material Agreement Details — 8-K · Oct 23, 2024
• Dare Bioscience Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 21, 2024
• Dare Bioscience Files 8-K on Financials — 8-K · Aug 12, 2024
• Dare Bioscience Files Q2 2024 10-Q Report — 10-Q · Aug 12, 2024
• Dare Bioscience Closes $15M Public Offering — 8-K · Jul 19, 2024
• Dare Bioscience Secures $50M Financing from OrbiMed — 8-K · Jun 27, 2024
• Dare Bioscience Holds Annual Stockholder Meeting — 8-K · Jun 7, 2024
• Dare Bioscience Files 8-K on Financials — 8-K · May 14, 2024
• Dare Bioscience, INC. 10-Q Filing — 10-Q · May 14, 2024
• Dare Bioscience Enters Material Agreement, Faces Financial Obligation — 8-K · Apr 30, 2024
• Dare Bioscience Announces 2024 Annual Meeting of Stockholders on June 5 — DEF 14A · Apr 26, 2024
• Dare Bioscience Files 8-K on Financials — 8-K · Mar 28, 2024
• Dare Bioscience, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Dare Bioscience Files Routine 8-K on Jan 26, 2024 — 8-K · Jan 26, 2024
• Dare Bioscience Faces Nasdaq Delisting Risk Over Bid Price — 8-K · Jan 19, 2024
• Dare Bioscience Files 8-K: Regulation FD Disclosure & Exhibits — 8-K · Jan 8, 2024